New Zealand Crown Research Institute
AgResearch has
announced a bold $19.6 million plan to turn its major campuses
into Science Innovation Centres, investing a further $45 million
to bolster science capabilities and product development to
accelerate the commercialisation of scientific discoveries.
Chief Executive, Dr Keith Steele said AgResearch is now
moving into the next phase of its life sciences strategy with
the implementation of its 2003-2006 Strategic Plan – a programme
which has set the company some very ambitious targets.
"As a Crown Research Institute, AgResearch is an important
agent of economic transformation and seeks to assist the
Government in the achievement of its Growth and Innovation
strategy. We are keen to strengthen further New Zealand’s
reputation in biological sciences and particularly AgResearch’s
position in animal, plant and microbial sciences, as well as
environmental sustainability," Dr Steele said
AgResearch’s plans include a proposal which could see science
capabilities at the Wallaceville campus in Upper Hutt moved to
Grasslands in Palmerston North and Invermay near Dunedin, and
the Wallaceville campus closed. The plan is being presented to
staff as part of an eight week consultative process, before a
decision is made by the end of July.
Discussions are also being held with other stakeholders.
Dr Steele said historically, science facilities in New
Zealand have been distributed around the country – principally
near major cities. However modern-day advanced scientific
research is more complex and requires a critical mass of
scientific capabilities and advanced facilities for it to be
globally competitive.
AgResearch’s proposal is aimed at optimising infrastructure
and reducing duplication to ensure that the best economic value
from science will be extracted for New Zealand.
"Our science is world-renowned, and to retain both reputation
and global competitiveness, the Company must ensure it can be
sustained into the future."
"AgResearch’s plans for the future will allow it to better
provide the dynamic, responsive, multi-disciplinary approach to
delivering life science products and services demanded by New
Zealand and global enterprises," he said.